August 1, 2025The International Journal of NeuropsychopharmacologyOpen Access

Alleviating Opioid Withdrawal: From Rodents to Human Clinical Trial

View Full Paper

Ask AI

Bookmark

Opioid withdrawal is driven by hyperactivity in locus coeruleus neurons, leading to high noradrenaline levels in the cerebral spinal fluid.
The treatment targeting Pannexin-1 channels reduces withdrawal behaviors and noradrenaline release, based on rodent models.
This analysis employs advanced techniques such as chemogenetics and electrophysiology to uncover mechanistic insights.
Inhibiting Panx1 channels shows potential as a therapeutic strategy, with ongoing human clinical trials evaluating its efficacy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Analysis reveals locus coeruleus hyperactivity and noradrenaline's role in opioid withdrawal, suggesting Panx1 inhibition may alleviate symptoms in humans.

Cite This Study

T. Trang (2025) studied this question.

synapsesocial.com/papers/68af2ee5cf1dd9ea359e67c7 https://doi.org/10.1093/ijnp/pyaf052.375

View Full Paper

Ask AI

Bookmark

Implication

Analysis reveals locus coeruleus hyperactivity and noradrenaline's role in opioid withdrawal, suggesting Panx1 inhibition may alleviate symptoms in humans.

Alleviating Opioid Withdrawal: From Rodents to Human Clinical Trial

Key Points

Discussion

Implication

Cite This Study

Alleviating Opioid Withdrawal: From Rodents to Human Clinical Trial

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading